Journal article
MM-128: Carfilzomib, Dexamethasone, and Daratumumab (KdD) Versus Carfilzomib and Dexamethasone (Kd) in Relapsed or Refractory Multiple Myeloma (RRMM): Subgroup Analysis of the Phase 3 CANDOR Study by Number of Prior Lines of Therapy (pLOTs) and Prior Therapies
Hang Quach, Ajay Nooka, Olga Samoylova, Christopher Venner, Kihyun Kim, Thierry Facon, Andrew Spencer, Saad Usmani, Sebastian Grosicki, Kenshi Suzuki, Sosana Delimpasi, Katja Weisel, Mihaela Obreja, Anita Zahlten-Kumeli, Maria-Victoria Mateos
Clinical Lymphoma Myeloma and Leukemia | Elsevier BV | Published : 2020